MAIA under the microscope — bringing trial design into focus

Research output: Contribution to journalArticle

5 Scopus citations


Using the example of the recently reported phase III MAIA trial, we emphasize herein the requirement to dig deeper into trial designs and end points to determine their appropriateness for the questions at hand and to assess whether a benefit in terms of the primary end point — even if statistically significant and seemingly clinically meaningful — is sufficient to warrant a change in clinical practice.

Original languageEnglish (US)
JournalNature Reviews Clinical Oncology
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'MAIA under the microscope — bringing trial design into focus'. Together they form a unique fingerprint.

  • Cite this